Business Segments · Total reserve balance

North American Pharmaceutical — Total reserve balance

McKesson North American Pharmaceutical — Total reserve balance remained flat by 0.0% to $14.00M in Q4 2025 compared to the prior quarter.

Analysis

StatementSegment
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ4 2025
Rolls up toRestructuring Reserve

How to read this metric

A decreasing balance suggests that restructuring programs are nearing completion, while an increasing balance indicates new or ongoing initiatives.

Detailed definition

This metric represents the cumulative liability balance set aside for specific restructuring or contingency programs wit...

Peer comparison

Similar to restructuring accruals found on the balance sheets of large diversified healthcare distributors.

Metric ID: mck_segment_north_american_pharmaceutical_total_reserve_balance

Historical Data

3 periods
 Q1 '25Q3 '25Q4 '25
Value$11.00M$14.00M$14.00M
QoQ Change—+27.3%+0.0%
Range$11.00M – $14.00M
Current Streak2+ quarters growth

Similar Metrics at Other Companies

Johnson & Johnson logo
Johnson & JohnsonJNJView metric
S&P Global logo
S&P GlobalSPGIView metric
CVS Health logo
CVS HealthCVSView metric
S&P Global logo
S&P GlobalSPGIView metric
Amazon logo
AmazonAMZNView metric
S&P Global logo
S&P GlobalSPGIView metric

Frequently Asked Questions

What is McKesson's north american pharmaceutical — total reserve balance?
McKesson (MCK) reported north american pharmaceutical — total reserve balance of $14.00M in Q4 2025.
What does north american pharmaceutical — total reserve balance mean?
The total amount of funds currently held in reserve for future restructuring-related obligations in the North American Pharmaceutical segment.